R-R-1H-benzimidazole-2-methanamine [R-bimaH, 1], for
Ru-based aryl ketone AH.
Scheme 1. Asymmetric Hydrogenation of Aryl Ketones
Both the (S)- and (R)-configuration of 1 were readily
obtained from simple condensation of 1,2-diaminobenzene
with the corresponding amino acid via established methods.10
Trials using in situ generated catalysts derived from 1-3
and RuCl2[(S)-binap](dmf)n [(S)-4]11 or trans-RuCl2[(R,S)-
Josiphos](pyridine)2 [(R,S)-5]12 for AH of acetophenone (6a)
revealed that systems based on 1 uncharacteristically per-
formed well in both protic and nonprotic solvents (toluene,
Et2O, THF), Table 1.13,14 Previous reactivity in nonprotic
Catalyzed by in Situ Generated Ru Complexes (4,5/1) or
RuCl2[(R,S)-Josiphos)][(S)-Me-bimaH)] [(RS,S)-8] Complex
(Idealized Configuration Shown)
Table 1. Asymmetric Hydrogenation of Acetophenone (6a)
Catalyzed by in Situ Generated Catalysts Comprised of
RuCl2(binap)(dmf)n (4) or trans-RuCl2[(R,S)-Josiphos](pyridine)2
[(R,S)-5] and Hybrid Ligands (1-3)a
catalyst
components
time yield eeb (%)
entry complex ligand
additive
solvent (h) (%) (config)
1
2
3
4
5
6
7
8
9
(S)-4
(S)-4
(S)-4
(R)-4
(S)-4
(S)-4
(S)-4
1a
1a
(S)-1b
(R)-1b
(S)-1b
(S)-1c
(S)-1d
toluene
i-PrOH
toluene
toluene
i-PrOH
toluene 12 100 87 (S)
toluene 10 100 91 (S)
toluene
toluene
toluene
toluene
toluene
i-PrOH
8
8
8
8
8
100 77 (S)
100 25 (S)
100 91 (S)
100 91 (R)
100 28 (S)
(R,S)-5 1a
(R,S)-5 (S)-1b
P(C6H5)3
9
9
9
9
9
9
100 82 (S)
95 91 (S)
100 96 (S)
100 96 (S)
50 93 (S)
100 30 (R)
92 95 (R)
100 78 (S)
100 93 (S)
100 89 (S)
100 92 (S)
10 (R,S)-5 (S)-1b P(C6H5)3
11 (R,S)-5 (S)-1c P(C6H5)3
12 (R,S)-5 (S)-1d P(C6H5)3
13 (R,S)-5 (S)-2
14c (R,S)-5 (S)-3
i-PrOH 10
15 (R,S)-5 (S)-1b P(C6H5)3
16 (R,S)-5 (S)-1b P(C6H5)3
17 (R,S)-5 (S)-1b P(C6H5)3
18 (R,S)-5 (S)-1b P(C6H5)3
19 (R,S)-5 (S)-1b P(4-ClC6H4)3
i-PrOH
t-BuOH
THF
9
8
9
9
Et2O
toluene 12 100 90 (S)
20 (R,S)-5 (S)-1b P[3,5-(C6H5)2C6H3]3 toluene 12 100 82 (S)
21 (R,S)-5 (S)-1b P(CH2CH2CH2CH3)3 toluene 18 52 98 (S)
enzymatic processes and catalyzes.9 Accordingly, we herein
report the application of NH2/benzimidazole hybrid ligands,
a Hydrogenation conditions: [6a] ) 0.33 M, [4 or 5] ) 0.33 mM, [1, 2,
or 3] ) 0.33 mM, P(H2) ) 8 atm, [KO-t-C4H9] ) 20 mM, [additive] ) 1.0
mM (3 equiv), T ) 25 °C. b Enantiomeric excess (ee) determined by GC
analysis; absolute configuration (config) determined from [R]D measurement.
c P(H2) ) 2 atm, [NaO-t-C4H9] ) 20 mM.
(6) (a) Genov, D. G.; Ager, D. J. Angew. Chem., Int. Ed. 2004, 43, 2816–
2819. (b) Abdur-Rashid, K.; Guo, R.; Lough, A. J.; Morris, R. H.; Songa,
D. AdV. Synth. Catal. 2005, 347, 571–579. (c) Chen, W.; Mbafor, W.;
Roberts, S. M.; Whittall, J. Tetrahedron: Asymmetry 2006, 17, 1161–1164.
(d) Ohkuma, T.; Utsumi, N.; Watanabe, M.; Tsutsumi, K.; Arai, N.; Murata,
K. Org. Lett. 2007, 9, 2565–2567. (e) Arai, N.; Ooka, H.; Azuma, K.;
Yabuuchi, T.; Kurono, N.; Inoue, T.; Ohkuma, T. Org. Lett. 2007, 9, 939–
941. (f) Saudan, L. A.; Saudan, C. M.; Debieux, C.; Wyss, P. Angew. Chem.,
Int. Ed. 2007, 46, 7473–7476. (g) Clarke, M. L.; Diaz-Valenzuela, M. B.;
Slawin, A. M. Z. Organometallics 2007, 26, 16–19. (h) Ito, M.; Sakaguchi,
A.; Kobayashi, C.; Ikariya, T. J. Am. Chem. Soc. 2007, 129, 290–291. (i)
Dahlenburg, L.; Ku¨hnlein, C. Inorg. Chim. Acta 2008, 361, 2785–2791. (j)
Arai, N.; Azuma, K.; Nii, N.; Ohkuma, T. Angew. Chem., Int. Ed. 2008,
47, 7457–7460.
solvents for related systems has been limited to reactive
Ru-hydride complexes representative of the active
catalyst.4a,7b,c,15,16 Better catalytic performance was obtained
for homochiral combinations, (S)-4/(S)-1 and (R,S)-5/(S)-1,
noting that the latter generally gave higher enantiomeric
excess (ee) values for 7a. Only a small influence on
enantioselectivity was exerted by the R group in 1. In
addition, for (R,S)-5/(S)-1b systems, the optical purity of
product alcohol was largely influenced by phosphine addi-
tives (regardless of the solvent media). Thus, the obtained
ee for (S)-7a varied from 82-98% depending on the
phosphine additive used. Despite of the structural similarities
(7) (a) Ohkuma, T.; Sandoval, C. A.; Srinivasan, R.; Lin, Q.; Wei, Y.;
Mun˜iz, K.; Noyori, R. J. Am. Chem. Soc. 2005, 127, 8288–8289. (b) Abdur-
Rashid, K.; Abbel, R.; Hadzovic, A.; Lough, A. J.; Morris, R. H. Inorg.
Chem. 2005, 44, 2483–2492. (c) Hadzovic, A.; Song, D.; MacLaughlin,
C. M.; Morris, R. H. Organometallics 2007, 26, 5987–5999. (d) Arai, N.;
Suzuki, K.; Sugizaki, S.; Sorimachi, H.; Ohkuma, T. Angew. Chem., Int.
Ed. 2008, 47, 1770–1773. (e) Baratta, W.; Ballico, M.; Chelucci, G.; Siega,
K.; Rigo, P. Angew. Chem., Int. Ed. 2008, 47, 4362–4365.
(8) Isolated homochiral 5/3 complex has previously been developed by
Baratta and co-workers for efficient catalytic asymmetric transfer hydro-
genation of aryl ketones; see: (a) Baratta, W.; Chelucci, G.; Herdtweck,
E.; Magnolia, S.; Siega, K.; Rigo, P. Angew. Chem., Int. Ed. 2007, 46,
7651–7654. (b) Baratta, W.; Rigo, P. Eur. J. Inorg. Chem. 2008, 4041–
4053.
(9) Selected representative examples: (a) Lodi, P. J.; Knowles, J. R.
Biochemistry 1991, 30, 6948–6956. (b) Brenner, C. Biochemistry 2002, 41,
9003–9014. (c) Ishida, T.; Kato, S. J. Am. Chem. Soc. 2003, 125, 12035–
12048. (d) Ishida, T. Biochemistry 2006, 45, 5413–5420. (e) Scheiner, S.
J. Phys. Chem. B 2008, 112, 6837–6846.
908
Org. Lett., Vol. 11, No. 4, 2009